Latest Breaking News On - சிரோன் பெஹ்ரிங் தடுப்பு மருந்துகள் - Page 1 : comparemela.com
Global Vaccines Markets, 2015-2020, 2020-2025F, 2030F: Anti-Infective, Vaccines Autoimmunity, Cancer, Conjugate, Inactivated and Subunit, Live Attenuated, Recombinant, Toxoid, Monovalent, Multivalent
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Vaccines Markets, 2015-2020, 2020-2025F, 2030F: Anti-Infective, Vaccines Autoimmunity, Cancer, Conjugate, Inactivated and Subunit, Live Attenuated, Recombinant, Toxoid, Monovalent, Multivalent
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global $95.9 Billion Vaccines Markets, 2015-2019, 2023F, 2025F, 2030F
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
28 May 2021
Bharat Biotech s vaccine against the Wuhan virus, Covaxin, has obtained emergency use authorisation in 13 countries, even as the country is working on expediting vaccine production to meet on-demand jabs by August this year.
Bharat Biotech on Tuesday said that regulatory approval for its new coronavirus vaccine, developed in partnership with the India Council for Medical Research (ICMR), is under the EUA process in over 60 countries, including the USA, Brazil and Hungary among others.
The Hyderabad-based pharma company has also submitted an application for EUL to the World Health Organisation (WHO), in a bid to ease EUAs in several other countries. It expects WHO s regulatory approvals by July-September this year.
URL copied
Covaxin has reached 30 cities in the past 30 days
Covaxin, India s indigenous Covid-19 vaccine, has reached 30 cities in the past 30 days, said the vaccine manufacturer Bharat Biotech in a statement on Tuesday. Among 30 cities that have received the Covaxin doses include Delhi, Kolkata, Mumbai, Chennai, Bengaluru, Kochi and Amritsar.
Covaxin is one of the three vaccines that the DGCI has cleared for emergency use in India. The two others are Covishield and Sputnik V. While Covishield is the local version of Oxford-AstraZeneca COVID-19 vaccine and being manufactured by Pune-based Serum Institute of India, Sputnik V is a Russian drug.